SCHEMBL4658235

SCHEMBL4658235

CC(CCc1cccc([N+](=O)[O-])c1)C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.52
TSHR P16473 2/20 0.49
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
RECQL P46063 1/20 0.48
GRM8 O00222 1/20 0.47
GRM6 O15303 1/20 0.47
GRM4 Q14833 1/20 0.47
ALDH1A1 P00352 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
KDM4E B2RXH2 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
PRSS1 P07477 1/20 0.46
PRSS2 P07478 1/20 0.46
PRSS3 P35030 1/20 0.46
TRPV1 Q8NER1 1/20 0.45
MAOB P27338 2/20 0.45
MAOA P21397 1/20 0.45
PTPN1 P18031 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4658039 0.87 CYP2D6 (0.52) TSHRCYP2D6CYP2C9CYP2C19RECQL
SCHEMBL30514028 0.86 EPHX1 (0.54) EPHX1TSHRCYP2D6CYP2C9CYP2C19
SCHEMBL10650422 0.82 TSHR (0.54) EPHX1TSHRCYP2D6CYP2C9CYP2C19
SCHEMBL29466702 0.82 TSHR (0.57) TSHRCYP2D6CYP2C9CYP2C19RECQL
SCHEMBL15562841 0.82 TSHR (0.57) TSHRCYP2D6CYP2C9CYP2C19RECQL
SCHEMBL31033035 0.78 TRPV1 (0.56) EPHX1TSHRALDH1A1TRPV1
SCHEMBL3723195 0.78 TRPV1 (0.56) EPHX1TSHRALDH1A1TRPV1
SCHEMBL25500059 0.78 TSHR (0.44) EPHX1TSHRL3MBTL1TDP1
SCHEMBL29137550 0.78 GRM8 (0.50) TSHRCYP2D6CYP2C9CYP2C19RECQL
SCHEMBL8804832 0.77 CYP2C19 (0.62) EPHX1TSHRCYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1295864-B1 PROCESS FOR PREPARATION OF 1,5-DIAMINONAPHTHALENES MITSUI CHEMICALS POLYURETHANES (JP) 2008-12-03 EP disclosed
US-6737548-B2 REACTING AN ORTHO-ALKYLNITROBENZENE WITH VINYL COMPOUND IN PRESENCE OF A BASE TO PRODUCE AN INTERMEDIATE, CYCLIZING THE INTERMEDIATE TO FORM 5-NITRO-1-TETRALONE COMPOUND, THEN REACTING WITH AMINE TO PRODUCE DIAMINONAPHTHALENE COMPOUNDS MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20030176722-A1 Process for preparation of 1,5-diaminonaphthalenes MITSUI CHEMICALS POLYURETHANES, INC. (JP) 2003-09-18 US disclosed
EP-1295864-A1 PROCESS FOR PREPARATION OF 1,5-DIAMINONAPHTHALENES Mitsui Chemicals, Inc. (JP) 2003-03-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176722-A1 Process for preparation of 1,5-diaminonaphthalenes NOX5, NOX1, DPYD EPHX1 3622/4885TSHR 4208/4885CYP2D6 191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.